Uncategorized Pherecydes Pharma expands its patent portfolio with a new patent granted in Hong Kong 16 May 2021 Pherecydes Pharma (Paris:ALPHE) (FR0011651694 - ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announced that the Hong Kong authorities have granted a…
PHAGElogist 